Agios Pharmaceuticals (NASDAQ:AGIO) used its presentation at the 44th Annual J.P. Morgan Healthcare Conference to outline its ...
Combing through scientific literature, Casgevy’s creators found that adults with genes that would normally produce sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT), but who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback